Centessa Pharmaceuticals (CNTA) PT Raised to $24 at Leerink Partners
Tweet Send to a Friend
Leerink Partners analyst David Risinger raised the price target on Centessa Pharmaceuticals (NASDAQ: CNTA) to $24.00 (from $22.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
